Extremities

DePuy Synthes Launches 2.7 mm Variable Angle Locking Compression Plate Clavicle System Designed to Accommodate Different Shapes and Sizes of the Collarbone

New Offering Features Enhanced Plate-to-Bone Fit and Reduced Prominence

WEST CHESTER, PA – June 9, 2021 – Today, The Johnson & Johnson Medical Devices Companies* announced that DePuy Synthes** has launched the 2.7 mm Variable Angle Locking Compression Plate (VA LCP®) Clavicle Plate System for the treatment of lateral, shaft and medial fractures for small, medium and large clavicles.1 This new system offers plate shapes that reflect the correlation between patient stature and clavicle size to match the bow and contour of the clavicle and accommodate a broad range of anatomic variability of the clavicle.2 The VA LCP® Clavicle Plate System offers thinner plates, a more accurate plate-to-bone fit, and reduced prominence.2+

Clavicle fractures, or breaks in the collarbone, account for approximately 5 percent of all adult fractures.3 In complicated cases, patients may need surgery using fixation devices to realign the collarbone.4 One of the most common complications from this surgery is the need for hardware removal due to irritation caused by prominent plates.4

“The next generation VA clavicle plate system was designed as a result of collaborative and integrated morphological and epidemiological research by the AO Research Institute, the AO Technical Commission, and the DePuy Synthes Upper Extremity Research & Development team,” said Simon Lambert of London, England who serves as Orthopaedic Surgeon and chairman of the AO Technical Commission Upper Extremity Global Expert Committee*** who assisted in the development of the System. “This system provides an optimized sequence of lengths with novel shape and form; matching the spectrum of adult clavicle dimensions, with better plate fit, optimized fixation of fractures in all adult patient groups, and a potentially reduced need for implant removal due to plate prominence.”

Throughout the development process for the 2.7mm VA LCP® Clavicle System, DePuy Synthes conducted extensive research; examining more than 600 clavicle CT scans from a broad-based patient population and analyzing 15 different parameters on each bone to identify the correlation between patient height and clavicle shape.5 The data was used to engineer lower profile plates with enhanced plate to bone fit for a broad range of patients with different statures, including those with small statures.2+

“There is a tremendous need for treatment options that can accommodate the anatomic variability of the clavicle in patients who experience these types of fractures” said I.V. Hall****, Worldwide President, Trauma, Extremities, CMF and Animal Health, DePuy Synthes. “We are incredibly proud to offer this new system as part of our comprehensive Extremities portfolio.”

The VA LCP® Clavicle System is launching globally this year. To learn more click here.

About Johnson & Johnson Medical Devices Companies
At Johnson & Johnson Medical Devices Companies, we are helping people live their best lives. Building on more than a century of expertise, we tackle pressing healthcare challenges, and take bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision and interventional solutions, we are helping to save lives and paving the way to a healthier future for everyone, everywhere.

About DePuy Synthes
DePuy Synthes, the Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS™ Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. 

Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. For more information, visit www.depuysynthes.com

Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the 2.7 mm Variable Angle Locking Compression Plate Clavicle System. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of DePuy Synthes, Inc. and/or Johnson & Johnson.  Risks and uncertainties include, but are not limited to: uncertainty of regulatory approvals; uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 3, 2021, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in the company’s most recently filed Quarterly Report on Form 10-Q, and the company’s subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.govwww.jnj.com or on request from Johnson & Johnson. Neither DePuy Synthes, Inc. nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.

FOR IMMEDIATE RELEASE CONTACT:

Meghan Grimaldi
Mgrimal4@its.jnj.com

*Comprising the surgery, orthopaedics, vision and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment
**DePuy Synthes represents the products and services of DePuy Synthes Sales, Inc. and its affiliates.
**** I.V. Hall is an employee of Medical Device Business Services, Inc.
*** The AO Research Institute and the AO Technical Commission are part of the AO Foundation, an independent, medically-guided, not-for-profit organization, a global network of surgeons, and the world’s leading education, innovation, and research organization specializing in the surgical treatment of trauma and musculoskeletal disorders, funded in part by DePuy Synthes. 
**** I.V. Hall is an employee of Medical Device Business Services, Inc.

1. DePuy Synthes 2.7mm VA LCP Clavicle Plates Surgical Technique Guide, 103752541 rev 2 01/21.
2. DePuy Synthes. Shape Verification Analyses. Windchill #0000290902, 0000295170, 0000290186, 0000290903, 2020.
3. Robinson CM. Fractures of the clavicle in the adult. Epidemiology and classification. J Bone Joint Surg Br. 1998;80:476-484.
4. Iannotti MR, Crosby LA, Stafford P, Grayson G, Goulet R. Effects of plate location and selection on the stability of midshaft clavicle osteotomies: a biomechanical study. J Shoulder Elbow Surg. 2002; 11(5):457-462.
5. DePuy Synthes. Shape Verification Analyses. Windchill #0000294539, 2020. Fontana AD, Hoyen HA, Blauth M, et al. The variance of clavicle surface morphology is predictable: an analysis of dependent and independent metadata variables. JSES International, https://doi.org/10.1016/j.jseint.2020.05.004
+Compared to Stryker Variax 2 Clavicle System, Acumed Clavicle System and DePuy Synthes 3.5mm LCP® Clavicle System.

The third party trademarks used herein are the trademarks of their respective owners.

Please refer to the instructions for use for a complete list of indications, contraindications, warnings and precautions.

Please also refer to the package insert(s) or other labeling associated with the devices identified in this document for additional information.

177063-210517 DSUS

© DePuy Synthes 2021. All rights reserved

Print Friendly, PDF & Email
Tags

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
Close